Literature DB >> 29480515

Predictive risk factors for recurrent atrial fibrillation after modified endoscopic ablation: A 2-year follow-up.

Kang An1, Jiaquan Zhu1, Nan Ma1, Min Tang1, Ju Mei1.   

Abstract

BACKGROUND: Our previous study reported a modified endoscopic procedure for nonvalvular atrial fibrillation (AF) that requires only 3 ports in the left chest wall. HYPOTHESIS: Certain preoperative variables might be predictive risk factors for AF recurrence among patients who underwent this procedure.
METHODS: From October 2010 to April 2014, 114 patients with either paroxysmal AF (PAF) or nonparoxysmal AF (non-PAF) underwent the procedure and completed postoperative cardiac-rhythm measurement via electrocardiography and Holter monitoring. Univariate and multivariate analyses of the possible AF-related risk factors were conducted.
RESULTS: During 2-year follow-up, 99 of 114 patients (86.8%) were free from atrial tachyarrhythmia. Results from univariate analyses showed that AF duration, left atrial diameter (LAD), left atrial minimum volume, left atrial empty fraction, left atrial expansion index, and left atrial active empty fraction (LAAEF) were significantly associated with postoperative AF recurrence. Results from multivariate analyses showed that AF duration (odds ratio [OR]: 1.194, 95% CI: 1.063-1.340, P = 0.003), LAD (OR: 1.101, 95% CI: 1.005-1.205, P = 0.039), and LAAEF (OR: 0.490, 95% CI: 0.277-0.865, P = 0.014) were independent risk factors. There was no difference in AF recurrence between patients with PAF and non-PAF (P = 0.250).
CONCLUSIONS: Our 2-year follow-up study suggested that low LAAEF, long AF duration, and large LAD might be potential predictive risk factors for AF recurrence. Patients with PAF and non-PAF had a similar AF recurrence rate after modified endoscopic ablation.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Atrial Fibrillation; Modified Endoscopic Ablation; Recurrence; Risk Factors

Mesh:

Year:  2018        PMID: 29480515      PMCID: PMC6489699          DOI: 10.1002/clc.22878

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  29 in total

Review 1.  Left atrial size and function: role in prognosis.

Authors:  Brian D Hoit
Journal:  J Am Coll Cardiol       Date:  2013-11-27       Impact factor: 24.094

2.  Pre-operative left atrial mechanical function predicts risk of atrial fibrillation following cardiac surgery.

Authors:  Jessica A Haffajee; Yoojin Lee; Alawi A Alsheikh-Ali; Jeffrey T Kuvin; Natesa G Pandian; Ayan R Patel
Journal:  JACC Cardiovasc Imaging       Date:  2011-08

3.  Thoracoscopic pulmonary vein isolation in patients with atrial fibrillation and failed percutaneous ablation.

Authors:  Manuel Castellá; Daniel Pereda; Carlos A Mestres; Félix Gómez; Eduard Quintana; Jaume Mulet
Journal:  J Thorac Cardiovasc Surg       Date:  2010-02-01       Impact factor: 5.209

4.  Left atrial passive emptying function determined by cardiac magnetic resonance predicts atrial fibrillation recurrence after pulmonary vein isolation.

Authors:  John A Dodson; Tomas G Neilan; Ravi V Shah; Hoshang Farhad; Ron Blankstein; Michael Steigner; Gregory F Michaud; Roy John; Siddique A Abbasi; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Circ Cardiovasc Imaging       Date:  2014-06-05       Impact factor: 7.792

5.  Late recurrent arrhythmias after ablation of atrial fibrillation: incidence, mechanisms, and treatment.

Authors:  Richard Kobza; Gerhard Hindricks; Hildegard Tanner; Petra Schirdewahn; Anja Dorszewski; Christopher Piorkowski; Jin-Hong Gerds-Li; Hans Kottkamp
Journal:  Heart Rhythm       Date:  2004-12       Impact factor: 6.343

6.  Mid-term outcomes of the modified Cox-maze procedure for elderly patients: a risk analysis for failure.

Authors:  Teruya Nakamura; Hironori Izutani; Yoshiki Sawa
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-03-23

7.  Left ventricular diastolic dysfunction in patients with so-called lone atrial fibrillation.

Authors:  P Jaïs; J T Peng; D C Shah; S Garrigue; M Hocini; T Yamane; M Haïssaguerre; S S Barold; R Roudaut; J Clémenty
Journal:  J Cardiovasc Electrophysiol       Date:  2000-06

8.  Efficacy and safety of novel epicardial circumferential left atrial ablation with pulmonary vein isolation in sustained atrial fibrillation.

Authors:  Zhaolei Jiang; Hang Yin; Yi He; Nan Ma; Min Tang; Hao Liu; Fangbao Ding; Ju Mei
Journal:  Heart Vessels       Date:  2014-10-17       Impact factor: 2.037

9.  Left atrial function predicts heart failure hospitalization in subjects with preserved ejection fraction and coronary heart disease: longitudinal data from the Heart and Soul Study.

Authors:  Christine C Welles; Ivy A Ku; Damon M Kwan; Mary A Whooley; Nelson B Schiller; Mintu P Turakhia
Journal:  J Am Coll Cardiol       Date:  2012-02-14       Impact factor: 24.094

10.  Analysis of risk factors for recurrence after video-assisted pulmonary vein isolation of lone atrial fibrillation--results of 5 years of follow-up.

Authors:  Qiu-Ming Hu; Yan Li; Chun-Lei Xu; Jie Han; Hai-Bo Zhang; Wei Han; Xu Meng
Journal:  J Thorac Cardiovasc Surg       Date:  2014-03-31       Impact factor: 5.209

View more
  3 in total

1.  Predictive risk factors for recurrent atrial fibrillation after modified endoscopic ablation: A 2-year follow-up.

Authors:  Kang An; Jiaquan Zhu; Nan Ma; Min Tang; Ju Mei
Journal:  Clin Cardiol       Date:  2018-02-26       Impact factor: 2.882

2.  Morphological and functional parameters of left atrial appendage play a greater role in atrial fibrillation relapse after radiofrequency ablation.

Authors:  Xin Tian; Xue-Jing Zhang; Ying-Fang Yuan; Cai-Ying Li; Li-Xia Zhou; Bu-Lang Gao
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

3.  The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome.

Authors:  Hsiang-Chun Lee; Shyi-Jang Shin; Jih-Kai Huang; Ming-Yen Lin; Yu-Hsun Lin; Liang-Yin Ke; He-Jiun Jiang; Wei-Chung Tsai; Min-Fang Chao; Yi-Hsiung Lin
Journal:  Lipids Health Dis       Date:  2020-09-22       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.